| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.28B | 52.56B | 50.59B | 45.49B | 35.80B | 35.43B |
| Gross Profit | 20.21B | 20.34B | 19.65B | 18.44B | 15.71B | 12.78B |
| EBITDA | 2.21B | 2.50B | 2.41B | 104.00M | 622.00M | -3.71B |
| Net Income | 1.30B | 1.17B | 1.33B | -769.00M | -769.00M | -4.87B |
Balance Sheet | ||||||
| Total Assets | 28.95B | 29.52B | 33.52B | 33.19B | 33.74B | 35.13B |
| Cash, Cash Equivalents and Short-Term Investments | 4.83B | 5.39B | 9.01B | 8.16B | 8.28B | 6.87B |
| Total Debt | 8.83B | 8.81B | 13.98B | 14.75B | 15.30B | 16.39B |
| Total Liabilities | 17.73B | 18.24B | 23.12B | 23.70B | 23.67B | 23.99B |
| Stockholders Equity | 11.22B | 11.29B | 10.40B | 9.48B | 10.06B | 11.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.28B | 714.00M | -462.00M | 2.61B | -7.69B |
| Operating Cash Flow | 0.00 | 2.15B | 1.54B | 784.00M | 3.40B | -6.47B |
| Investing Cash Flow | 0.00 | 295.00M | 370.00M | -372.00M | -665.00M | 1.84B |
| Financing Cash Flow | 0.00 | -5.47B | -1.04B | -544.00M | -1.38B | 331.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | ¥30.56B | 13.20 | ― | ― | 3.45% | -22.80% | |
65 Neutral | ¥25.07B | 59.36 | ― | ― | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥23.99B | 20.47 | ― | 1.20% | 3.89% | -12.08% | |
60 Neutral | ¥23.61B | 23.59 | ― | 0.81% | 0.32% | 10.22% | |
57 Neutral | ¥22.54B | 75.84 | ― | 0.78% | 8.86% | -17.71% | |
52 Neutral | ¥21.96B | 64.06 | ― | 0.62% | 7.64% | -65.84% |